(Q33829739)

English

Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: experience from a consecutive cohort of inflammatory bowel disease patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: experience from a consecutive cohort of inflammatory bowel disease patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

inflammatory bowel diseases

0 references

0 references

Ulrike Grittner

object named as

Ulrike Grittner

2

0 references

author name string

Daniel C Baumgart

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Andrea Steingräber

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Marina Azzaro

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sandra Philipp

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

23 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

2512-2520

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Inflammatory bowel disease: clinical aspects and established and evolving therapies

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Inflammatory bowel disease: cause and immunobiology

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Treatment of ulcerative colitis with adalimumab or infliximab: long-term follow-up of a single-centre cohort

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Safety of infliximab and other biologic agents in the inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

A simple index of Crohn's-disease activity

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Cortisone in ulcerative colitis; final report on a therapeutic trial.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010--Inflammatory Bowel Disease Task Force meeting.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Dosage adjustment during long-term adalimumab treatment for Crohn's disease: clinical efficacy and pharmacoeconomics

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

On the Interpretation of χ 2 from Contingency Tables, and the Calculation of P

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

THE EXTRA-INTESTINAL COMPLICATIONS OF CROHNʼS DISEASE AND ULCERATIVE COLITIS: A STUDY OF 700 PATIENTS

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Stevens-Johnson syndrome complicating adalimumab therapy in Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Azathioprine hypersensitivity presenting as a neutrophilic dermatosis in a man with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Azathioprine treatment photosensitizes human skin to ultraviolet A radiation.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Cross-regulation of TNF and IFN-alpha in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Predictive Factors of Eczema-Like Eruptions among Patients without Cutaneous Psoriasis Receiving Infliximab: A Cohort Study of 92 Patients

1 reference

https://api.crossref.org/works/10.1002%2FIBD.21643

21 January 2018

Identifiers

10.1002/IBD.21643

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33829739&oldid=1950083177"